Both H19 and RMRP engage in cardiac hypertrophy and heart failure progression [42], while a BDNF-AS downregulation can activate BDNF, VEGF, and Akt, and thus rescue hypoxia/reoxygenation-induced damage in cardiomyocyte [43] (Fig. 3). The gene discussed is H19; the disease is cardiac hypertrophy.